This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Veeva Systems (VEEV) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
VEEVPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Amarin (AMRN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
AMRNPositive Net Change MNKDNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last?
by Zacks Equity Research
Capricor (CAPR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CAPRPositive Net Change MYONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?
by Zacks Equity Research
Outset Medical (OM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
OMPositive Net Change SENSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Grupo Cibest (CIB) Moves 5.5% Higher: Will This Strength Last?
by Zacks Equity Research
Grupo Cibest (CIB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CIBNegative Net Change KBCSYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Nu (NU): Can Its 8.8% Jump Turn into More Strength?
by Zacks Equity Research
Nu (NU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NUPositive Net Change BCHNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
by Zacks Equity Research
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
TDOCNegative Net Change BSXPositive Net Change GGGPositive Net Change STEMPositive Net Change CGENPositive Net Change MODPositive Net Change FWONAPositive Net Change STRONegative Net Change PGNYPositive Net Change LFMDNegative Net Change TTENegative Net Change INDVPositive Net Change RNACNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Exelixis (EXEL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
EXELPositive Net Change BSXPositive Net Change GGGPositive Net Change STEMPositive Net Change CGENPositive Net Change STRONegative Net Change PGNYPositive Net Change RNACNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength?
by Zacks Equity Research
Nektar (NKTR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
NKTRNegative Net Change BSXPositive Net Change GGGPositive Net Change STEMPositive Net Change CGENPositive Net Change MODPositive Net Change FWONAPositive Net Change STRONegative Net Change PGNYPositive Net Change INDVPositive Net Change RNACNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
XOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last?
by Zacks Equity Research
XOMA Royalty (XOMA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
XOMAPositive Net Change CGENPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Evolv Technologies (EVLV) Soars 5.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Evolv Technologies (EVLV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EVLVPositive Net Change STEMPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in CorMedix (CRMD): Can Its 21.7% Jump Turn into More Strength?
by Zacks Equity Research
CorMedix (CRMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CRMDPositive Net Change STRONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Euroseas Ltd. (ESEA) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
ESEAPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Iamgold (IAG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
IAGPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
ASML (ASML) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
ASMLNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Strength Seen in Northern Trust (NTRS): Can Its 8.0% Jump Turn into More Strength?
by Zacks Equity Research
Northern Trust (NTRS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
NTRSNegative Net Change MTBPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength?
by Zacks Equity Research
Brainsway (BWAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
BWAYPositive Net Change BSXPositive Net Change GGGPositive Net Change CGENPositive Net Change PGNYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
RGC Resources (RGCO) Surges 9.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
RGC Resources (RGCO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RGCONegative Net Change BSXPositive Net Change GGGPositive Net Change STEMPositive Net Change CGENPositive Net Change MODPositive Net Change FWONAPositive Net Change STRONegative Net Change PGNYPositive Net Change TTENegative Net Change INDVPositive Net Change RNACNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Graham (GHM) Surges 7.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Graham (GHM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GHMPositive Net Change GGGPositive Net Change CGENPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
GeneDx Holdings (WGS) Moves 19.0% Higher: Will This Strength Last?
by Zacks Equity Research
GeneDx Holdings (WGS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
WGSPositive Net Change GGGPositive Net Change CGENPositive Net Change PGNYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Mobileye (MBLY): Can Its 11.6% Jump Turn into More Strength?
by Zacks Equity Research
Mobileye (MBLY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MBLYPositive Net Change BSXPositive Net Change GGGPositive Net Change STEMPositive Net Change CGENPositive Net Change MODPositive Net Change STRONegative Net Change PGNYPositive Net Change RNACNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
BlackSky Technology (BKSY) Surges 11.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
BlackSky Technology (BKSY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BKSYPositive Net Change CAKEPositive Net Change FDXPositive Net Change AMWLNegative Net Change DUOLNegative Net Change QXOPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Adeia (ADEA) Moves 5.2% Higher: Will This Strength Last?
by Zacks Equity Research
Adeia (ADEA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ADEAPositive Net Change CAKEPositive Net Change FDXPositive Net Change AMWLNegative Net Change QXOPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Zeta (ZETA) Surges 12.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Zeta (ZETA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ZETAPositive Net Change CAKEPositive Net Change AIRPositive Net Change FDXPositive Net Change CRCPositive Net Change RMRPositive Net Change PTGXPositive Net Change IGICPositive Net Change AMWLNegative Net Change BLDEPositive Net Change DUOLNegative Net Change QXOPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
QGENNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines